The world’s first hybrid bioprinting technology can clone the detail required to recapitulate hard and soft tissue for human organs simultaneously. We Developed Magical Organ Cloner (MOC) system with several state of art technology to print several materials such as hydrogels, polymers, liquid composite, drugs, and special cell mediums with a unique intelligent injection system. MOC is an IoT system that could control the printing parameter automatically and its unique chamber is with incubation parameters so the printing time could be added and the patient’s stem cells vitality is assured. The world’s first scaffold treatment with laser and plasma is added in MOC so the stem cell adhesion and fermentation were increased significantly.

The need for replacing or repairing damaged tissues and organs becomes more perceptible every day. Hence, in recent decades, extensive research efforts have been undertaken in the field of public health for the design and development of biomaterials with a living scaffold to achieve biocompatibility and functionality goals but these products had major problems. The design and development of a fully integrated organ bio fabrication line or the development of a series of integrated automated robotic tools are imperative for the commercial translation of organ printing technology.

In this product with the help of unique and innovative production technology, robotic rapid prototyping, electrospinning, laser, and plasma surface modification, cutting, and stem cell injection, the mechanical properties are optimally optimized and the organ regeneration becomes much faster due to a different hemoglobin structure and its novel production. Certain medications have been used that can provide a suitable substrate for the growth of real organs Brought up Contrary to the samples of artificial organs and implants on the market and in laboratories. Novel 3D printing, stem cell rug delivery, and Nano tissue engineering technology, so we could clone several smart bandages related to each skin or wound problem and practically simultaneous treatment of missing organ problems. The process of organ bioprinting is divided into four main stages, the first three being directly dependent on information technology: design (blueprint), printing, maturation, and implantation. Organ regeneration is proceeding in less than one month. Finally, resistance to infections eliminates the patient’s healing in a very short time, which is a magical vital feature of the product.

MOC biotechnologies Inc. specializes in new bioprinting technologies and approaches to provide novel experiments in life sciences. Dr. Mousavi the co-founders used computer-aided manufacturing and design to develop a new class of organs and tissues with the potential to test the drugs and infections in life sciences.” The company plans to evaluate its best technological features with the ultimate goal of bringing to market truly new products.

It’s very interesting to collaborate with a professional individual man Arash Helmi. Techno company is a multi-million-dollar industry that imports its products to several countries such as Canada. We are so proud that this company Founder joins our MOC startup as co-founder and director of sales and marketing. Collaboration between science, industry, and business is MOC’s startup strength.

This startup collaborates with professors from renowned medical and engineering universities and conducts innovative research in medical devices and regenerative medicine. Our startup team strategically collaborates with world-class research centers to develop a portfolio of bioprinters that enable regenerative medicine through the development of implantable tissue therapies.